Author: admin

JEOMED Participates in the TOD 59th National Congress!

The TOD 59th National Congress, a key meeting point for eye health and ophthalmology professionals, was held from November 19–23, 2025 at Rixos Sungate Hotel & Congress Center, Antalya.

JEOMED was pleased to participate in this prestigious event and share our advanced ophthalmology and eye care solutions with colleagues.

During the congress:

• Our booth showcased a wide product portfolio, from medical aesthetic solutions to specialized eye care products, attracting significant attention and providing strong motivation.

• Scientific sessions, interactive panels, and roundtable meetings offered opportunities to closely follow the latest developments in ophthalmology and engage directly with leading experts.

• By participating in the industry exhibition area, we laid the foundation for collaboration and new project opportunities with other sector stakeholders.

We believe this participation strengthened JEOMED’s mission to extend its “Science through Beauty” vision into ophthalmology. We sincerely thank the entire organizing team and all participants who visited our booth and shared their insights with us.

We look forward to future gatherings with new developments and innovative solutions in the sector.

JEOMED Participates in the 27th Prof. Dr. A. Lütfü Tat Symposium!

One of the longstanding gatherings in the field of dermatology, the 27th Prof. Dr. A. Lütfü Tat Symposium, was held from November 19–23, 2025 in Ankara.

JEOMED was delighted to participate in this prestigious event and connect with industry professionals.

During the congress:

• We attended sessions focused on current approaches, clinical practices, and science-based solutions in dermatology.

• Our product portfolio was shared directly with physicians at our booth, receiving strong interest and valuable feedback.

• Interactions with industry stakeholders, researchers, and clinical experts created promising opportunities for collaborations and innovative projects in the near future.

We believe this event provided significant benefits in terms of scientific advancement, professional networking, and industry coordination. We sincerely thank everyone involved in organizing the symposium and all physicians and participants who visited our booth.

JEOMED continues its mission in aesthetic dermatology and dermocosmetics guided by the philosophy of “Science through Beauty.” We look forward to joining future events.

JEOMED Participates in the 4th Ankyra Dermatology Symposium!

One of the key gatherings in the field of dermatology, the 4th Ankyra Dermatology Symposium, was held from November 13–16, 2025 at Ethno Hotel, Belek, Antalya.

JEOMED was excited to participate in this scientific platform and connect with industry professionals.

During the congress, we shared the latest trends, technological developments, and clinical applications in dermatology and aesthetic treatments with our visitors. The strong interest in our products at the booth and feedback from physicians provided a significant source of motivation.

At this event:

• We explored skin treatments, cosmetic applications, filler and botox technologies, laser therapies, and mesotherapy in depth through scientific sessions and practical modules.

• JEOMED had the opportunity to present our product portfolio directly to participants and offer solutions tailored to their needs.

• Interactions with industry stakeholders, dermatologists, and researchers opened promising opportunities to expand collaborative initiatives and joint projects in the future.

We believe our participation strengthened industry communication and represented a meaningful step toward bridging the gap between science and practical application. We sincerely thank the congress organizers, physicians, and visitors who engaged with us at our booth.

JEOMED continues its mission in aesthetic dermatology guided by the philosophy of “Science through Beauty.” We look forward to joining future events with new innovations and developments.

JEOMED Participates in the 5th National Aesthetic and Cosmetic Dermatology Congress!

The 5th National Aesthetic and Cosmetic Dermatology Congress (EKDD 2025), one of the most prestigious events in the fields of aesthetic medicine and dermatology, was held from November 5–9, 2025 at Granada Luxury Belek, Antalya.

JEOMED proudly took part in this valuable gathering. Throughout the congress, we had the opportunity to showcase our innovative products in dermatology and medical aesthetics, engage directly with expert physicians, and share the latest developments in the sector.

Visitors at our booth were able to closely examine our scientifically formulated products, clinically tested dermocosmetic solutions, and professional product lines that support skin health.

The event, filled with scientific sessions, live demonstrations, and interactive panels, proved extremely productive both for knowledge sharing and fostering industry collaborations.

JEOMED is proud to be part of this influential gathering in aesthetic dermatology. We extend our gratitude to all participants, esteemed physicians, and visitors who contributed to the success of this congress.

We remain committed to adding value to the dermatology world and producing scientifically based solutions through our innovative product portfolio.

Speaking to an AA (Anadolu Agency) reporter about his visit, Varank noted that the company had launched a significant R&D and manufacturing project with OSTİM Technical University, adding: “They developed and commercialized Turkey’s first contact lens solution here.”

Stating that contact lens solutions had previously been imported and that there was a deficit of approximately 120 million dollars in this area, Varank said the company had obtained the necessary permits and certifications for the lens solutions it manufactures.

Varank underlined that contact lens users in Turkey now have access to a domestic, nationally developed product, and continued: “We are a government striving for development through production in Turkey. We attach particular importance to developing, with domestic and national means, value-added products, especially those in which we run a deficit. With the various supports and incentives of our state, particularly from KOSGEB, this company produced this product within the framework of university–industry collaboration.”

“We will issue a call focused on health and chemical products”

Referring to the Technology-Oriented Industry Move Program they launched, Varank said:
“From R&D to commercialization, we support as the state all stages of products in which we run a deficit; we provide support to our companies in the product groups we have identified. The chemicals and pharmaceuticals industries are among these. In the coming period, within the scope of the move program, we will issue a call and support projects in which our companies will produce products and medicines that are not currently manufactured in Turkey.”

Expressing satisfaction that Jeomed is producing lens solutions, an area with a deficit in Turkey, thanks to support from KOSGEB, Varank stated that they would continue to support localization initiatives across all sectors.

“We aim to export 6 million boxes in one year”

The company’s Chairman of the Board, Polat, said that in Jeomed’s early years they imported healthcare products, and later, when they could not achieve the desired quality with products contract-manufactured by pharmaceutical companies, they established their own production facilities.

Polat continued: “We wanted our products to be effective against bacteria, viruses, fungi, and parasites, and also to contain our country’s natural wealth—thermal waters. When we couldn’t achieve this with any manufacturer, we built our own ‘kitchen.’”

Pointing to Turkey’s richness in geothermal resources, Polat said: “We have always used geothermal water in our products. When our health products—rich in sulfur, vitamins, and minerals—were reinforced with tea tree oil as the active ingredient, we achieved distinctive shampoos, soaps, creams, and lotions.”

Polat noted that shampoos generally contain harmful active substances, whereas their products do not, and therefore can be used with confidence.

Explaining that they began selling their products, 14 of which are patented, to the world by participating in overseas congresses and international fairs, Polat said: “Users give positive feedback. As a result, we have built an export volume reaching 51 countries, including Greece, the United States, Russia, India, and Ecuador. With the contact lens solution we produce, we will further increase our exports. We aim to export 6 million boxes of lens solution within one year.”

Drawing attention to Turkey’s significant deficit in health products, Polat said: “Let’s trust our domestic products and support our domestic companies. As domestic firms succeed, we will invest, open new factories, buy new machinery. By employing many unemployed people, we will contribute to our country’s development. If we produce high value-added products, we can succeed.”

Source: Anadolu Agency (AA)

Producing Turkey’s first and only domestically developed contact lens solution with entirely local resources, Jeomed won the Pharmaceuticals & Health Products Manufacturer of the Year award at the Ankara Value-Added Awards (Ankara’ya Değer Katanlar Ödülleri).
Organized annually by the Ankara Journalists and Writers Association (AGYD), the awards ceremony was held on 30 March 2022 at the Ankara Chamber of Commerce (ATO) Assembly Hall.

Hosted by former Miss Turkey Nefise Karatay and veteran TRT news anchor Zafer Kiraz, the ceremony brought together many notable figures from the media, bureaucracy, business, arts, and society.

On behalf of Jeomed, the award was received by Chairman of the Board Süleyman Polat. In his remarks of thanks, Polat noted that the country is in an economic struggle, that investment and employment are essential, and that the company is passionate and ambitious in the field of health products. He stated that Jeomed exports to 51 countries, holds all necessary international certifications, and has 14 patented products.

JEOMED EXPORTS HEALTH PRODUCTS TO 51 COUNTRIES

Through a public university & industry collaboration model, Jeomed is advancing toward becoming a global brand in the lens solution market, an area with an annual foreign trade deficit of approximately 120 million USD, with its innovative products.

Jeomed supports the patents, formulations, processes, and clinical studies of more than 100 different products through KOSGEB and TÜBİTAK projects, delivering innovative solutions to the healthcare sector. Under 14 patents, Jeomed exports over 100 products to 51 countries, including Greece, India, Russia, and the United States, proudly representing our country in international markets.

As the Jeomed team, we had the opportunity to participate in this year’s 47th TODD Spring Symposium. Throughout the event, we closely followed the latest innovations, research, and developments in the healthcare and pharmaceutical sectors.

The symposium enabled us to meet leading academics, researchers, and professionals in the field, exchange knowledge, and share ideas. This valuable setting also allowed us to establish connections for future collaborations and develop solution-oriented proposals addressing industry needs.

At Jeomed, we not only introduced our products but also continued to present our innovative solutions that make a difference in healthcare. While highlighting the value we bring to the sector, we once again observed the importance of keeping pace with scientific progress and building strong partnerships.

Our goal is to create a strong and lasting impact in healthcare by delivering solutions that improve the quality of life for patients and healthcare professionals. Events like this symposium remain a major opportunity for us to broaden our vision, share knowledge with industry leaders, and take strategic steps toward the future.

Taking its commitment to science in healthcare one step further, Jeomed has sponsored the Demodex Diagnosis and Treatment book—an important resource in the field of dermatology. Among the authors is one of Türkiye’s leading dermatology specialists, Prof. Dr. Ayşe Serap Karadağ.

Prof. Dr. Ayşe Serap Karadağ is recognized nationally and internationally for her academic work, publications, and clinical expertise in dermatology. Her research on Demodex mites and skin health has guided her peers, and she has provided strong scientific foundations for the information presented in the book.

Prepared with Jeomed’s support, this work serves as a comprehensive reference for dermatologists on the diagnosis and treatment of Demodex. The book has been delivered free of charge to thousands of dermatologists across Türkiye, helping to disseminate scientific knowledge and support more effective solutions in clinical practice.

Jeomed continues not only to offer innovative products, but also to add value to science, research, and the medical community. With this approach, the company stands out as a pioneer supporting scientific advancement in the sector.